SMA Market Research

Are you living with SMA? We’d like to hear more about your experiences.

devices_other

Involvement

Online survey


timer

Commitment

60 minutes


Reward

$170 CAD

Who can apply to participate?

People in Canada living with SMA (Type 2 or 3) or their caregivers.

What’s involved?

We are conducting an online study to further understand what a meaningful change on the Motor Function Measure (MFM-32), an assessment that is used by clinical experts to assess SMA motor function ability, is from the perspective of individuals with SMA Type 2 or Type 3 and their caregivers. We want to better understand how changes on the MFM relate to daily life and the clinical meaningfulness of changes on the MFM-32. You will be asked to participate in a 60-minute online survey, during which you will be asked a series of questions relating to your experience of living with SMA and your current level of functional ability. There are no right or wrong answers, we are simply wanting to hear your opinions and views.
Please rest-assured that there will be no attempt to sell or promote anything to you during this conversation and that your details will be kept confidentially at all times.

As a thank you for your help?

You will receive $170 CAD for your time and opinions.

What Countries / Areas?

US Canada France Germany Italy Spain Poland

This project is sponsored by a pharmaceutical company – and your views and comments, along with those of others who are also living with SMAwill be fed back in an anonymised format.
By voluntarily providing your details below, you consent to Adept Field Solutions collecting and using the information for the purposes of contacting you for market research. You may opt out at any time and your personal data will not be shared with any third parties without your explicit consent.

By voluntarily providing your details below, you consent to Adept Field Solutions collecting and using the information for the purposes of contacting you for market research. You may opt out at any time and your personal data will not be shared with any third parties without your explicit consent.

Not suitable? Click here to join our patient community to be kept informed of future studies.